Profile | GDS4284 / 227929_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 165.813 | 46 |
GSM687648 | Patient 402 control | 531.858 | 65 |
GSM687653 | Patient 403 control | 203.871 | 50 |
GSM687658 | Patient 404 control | 528.709 | 65 |
GSM687663 | Patient 411 control | 642.99 | 67 |
GSM687668 | Patient 422 control | 419.29 | 61 |
GSM687673 | Patient 424 control | 484.026 | 62 |
GSM687678 | Patient 425 control | 604 | 66 |
GSM687683 | Patient 427 control | 401.705 | 59 |
GSM687688 | Patient 428 control | 203.819 | 49 |
GSM687695 | Patient 441 control | 3105.5 | 90 |
GSM687699 | Patient 443 control | 996.311 | 74 |
GSM687704 | Patient 444 control | 269.506 | 54 |
GSM687707 | Patient 448 control | 236.974 | 48 |
GSM687712 | Patient 449 control | 263.64 | 53 |
GSM687719 | Patient 450 control | 1232.36 | 77 |
GSM687724 | Patient 451 control | 431.568 | 61 |
GSM687728 | Patient 452 control | 3281.7 | 90 |
GSM687646 | Patient 401 treated 24h | 150.063 | 42 |
GSM687649 | Patient 402 treated 24h | 534.101 | 65 |
GSM687665 | Patient 411 treated 24h | 710.209 | 68 |
GSM687651 | Patient 402 treated 4 weeks | 415.699 | 60 |
GSM687667 | Patient 411 treated 4 weeks | 446.28 | 61 |
GSM687670 | Patient 422 treated 24h | 507.746 | 63 |
GSM687671 | Patient 422 treated 4 weeks | 445.585 | 62 |
GSM687654 | Patient 403 treated 24h | 145.552 | 44 |
GSM687675 | Patient 424 treated 24h | 578.306 | 65 |
GSM687685 | Patient 427 treated 24h | 445.045 | 61 |
GSM687656 | Patient 403 treated 4 weeks | 119.163 | 41 |
GSM687677 | Patient 424 treated 4 weeks | 151.09 | 43 |
GSM687687 | Patient 427 treated 4 weeks | 175.214 | 47 |
GSM687692 | Patient 428 treated 4h | 288.782 | 55 |
GSM687716 | Patient 449 treated 4h | 191.223 | 48 |
GSM687722 | Patient 450 treated 4h | 633.503 | 67 |
GSM687680 | Patient 425 treated 24h | 390.395 | 60 |
GSM687690 | Patient 428 treated 24h | 498.272 | 64 |
GSM687700 | Patient 443 treated 24h | 1692.78 | 82 |
GSM687705 | Patient 444 treated 24h | 746.431 | 70 |
GSM687714 | Patient 449 treated 24h | 345.598 | 59 |
GSM687721 | Patient 450 treated 24h | 1287.16 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 494.058 | 64 |
GSM687694 | Patient 428 treated 4 weeks | 344.933 | 58 |
GSM687702 | Patient 443 treated 4 weeks | 362.432 | 57 |
GSM687718 | Patient 449 treated 4 weeks | 107.158 | 35 |
GSM687723 | Patient 450 treated 4 weeks | 438.037 | 61 |
GSM687661 | Patient 404 treated 4h | 537.244 | 64 |
GSM687710 | Patient 448 treated 4h | 236.308 | 52 |
GSM687726 | Patient 451 treated 4h | 269.899 | 52 |
GSM687730 | Patient 452 treated 4h | 1582.67 | 82 |
GSM687660 | Patient 404 treated 24h | 5933.11 | 94 |
GSM687697 | Patient 441 treated 24h | 3082.31 | 90 |
GSM687709 | Patient 448 treated 24h | 470.211 | 63 |
GSM687725 | Patient 451 treated 24h | 480.12 | 62 |
GSM687729 | Patient 452 treated 24h | 7101.48 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 217.759 | 47 |
GSM687731 | Patient 452 treated 4 weeks | 1814.59 | 83 |